High-grade glioma pediatric · 4 regimens
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Temozolomide and RT Variant #01 | — | R 19 131 | 45d | ~7.9 mo | ~18.7 mo | ~12 | ~R 59 601 PFS proxy · indirect | 7 |
Vincristine and RT Variant #01 | — | R 3 266 | 70d | — | — | ~1 | ~R 3 266 indirect | — |
VCP Variant #01 Partial | — | R 1 019 | 42d | — | — | ~8 | ~R 8 155 indirect | — |
Lomustine, Vincristine, Prednisone Partial | — | — | — | — | — | — | — | — |
4 of 4 regimens shown